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Through  studies  of  structure-activity  relationships  with  benzimidazole 
derivatives and various viruses, compounds with interesting biological activities 
(1-19) have been obtained. In some instances, new biologically active deriva- 
tives were developed in the course of systematic attempts to increase,  through 
structural  alteration,  the virus inhibitory activity or selectivity of action of 
existing compounds (3, 5, 8). In other instances,  striking biological  activities 
of derivatives were discovered unexpectedly (10, 11, 19). It should be empha- 
sized that no direct inactivating effects on virus infectivity were found (2, 6, 
7,  13).  Most of  the  derivatives  inhibited  (1-9,  12,  15),  and  some of  them 
enhanced (10, 11, 18) virus multiplication; others had no effect. 
The purpose of the present investigation was to explore additional structural 
approaches to the problem of obtaining benzimidazole derivatives with further 
increased  virus  inhibitory  activity and  selectivity  of  action.  Discovery  of 
highly selective inhibitors of virus multiplication may aid greatly in studies of 
the chemical basis of virus specificity--a subject about which little is known 
today. 
The present report concerns the virus inhibitory activity and selectivity of 
a series of benzimidazole and benzotriazole derivatives which have been studied 
with influenza  B virus in the chorioallantoic membrane in vitro and with polio- 
virus type 2 in monkey kidney cell cultures. The results obtained confirm  the 
earlier conclusion  (1-3, 5, 8) that extensive substitution in either the benzenoid 
or  the  imidazole  ring  frequently gives compounds of very high virus inhibi- 
* Aided by a grant from The National Foundation. 
:~ An abstract, covering a part of this study, has appeared in J. Clin.  Inv.,  1959, 38, 1047. 
§ Present  Address: Merck Sharp and  Dohme  Research  Laboratories,  Westpoint,  Penn- 
sylvania. 
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tory  activity.  The  selective  action  of  2-(a-hydroxybenzyl)-benzimidazole 
(HBB)  (19)  as an inhibitor of poliovirus multiplication and cytopathic effects 
is  described.  Evidence  is  presented  concerning  structural  features  of  HBB 
which are of importance  for its selective virus inhibitory action. 
Materials and Methods 
Viruses.--Stock suspensions of the Lee (4) and "1760" (9) strains of influenza B virus and 
of the MEF1  (7)  strain of type 2 poliovirus were prepared and handled in  the manner de- 
scribed previously (4,  7, 9). 
Tissue Cultures.--Cultures  of chorioallantoi¢ membrane and of monkey kidney cells were 
similar to those used previously (4, 7). A medium designated buffered glucosol (9)  was used 
with the chorioallantoie membrane, and protein-free Eagle's medium (20) with monkey kidney 
cells.  Three membrane cultures or six monkey kidney cell cultures were used per variable. 
The inoculum of Lee virus was 2  X  105 EIDs0 (50 per cent egg infective doses) per cm? of 
freely suspended chorioallantoic membrane, and that of MEF1  virus was 5  X  102 TCIDs0 
(50 per cent tissue culture infective doses) per monolayer culture consisting of approximately 
2.5  X  105 cells.  Infected chorioallantoic membrane cultures were incubated at 35°C.  for 41 
hours and influenza virus was measured in the supernatant by the hemagglutination technique. 
Infected monkey kidney cell cultures were incubated at 36°C.  for 48 hours and poliovirus was 
measured in the supernatant by infectivity titrations. With each compound two or more ex- 
periments were carried out. 
Inhibitory  Activity  of Compounds.--The  molar  concentration of  compound  required  to 
cause 75 per cent reduction in yield of influenza or poliovirus was determined in the manner 
previously described  (4,  7). 
Toxicity  of Compou~ls.--The  molar  concentration  of  compound required  to cause 2+ 
macroscopic damage to chorioallantoic membrane (4) or 3+ microscopic damage to monkey 
kidney cells (7) was determined in the manner described previously. 
Selectivity Ratio.--To  obtain an estimate of the selectivity of  virus inhibitory action of 
compounds, the ratio of the toxic to the virus inhibitory concentration was computed (4, 7). 
Protective Activity  of Compounds against Virus-lnduced  Cell Damage.--Observations  on 
protection were not possible with influenza B virus in the chorioallantoic membrane because 
this virus does not cause definite macroscopic or microscopic changes in cells of the chorioal- 
lantoic  membrane  (4). 
Such observations were carried out with poliomyelitis and  influenza viruses in monkey 
kidney cell cultures. The amount of virus inoculated was 500 TCIDs0 per culture. The cul- 
tures were incubated in the presence or absence of a wide range of concentrations of various 
compounds and examined 48 hours after infection. In some instances cultures were examined 
daily for several days. The degree of virus-induced cell damage was expressed in terms of per 
cent cells affected. The extent of viral cytopathic effects in treated cultures was compared 
to that in untreated cultures. With many compounds no evidence of protection of cells against 
virus-induced damage was observed. In the presence of a number of compounds, virus-induced 
cell damage was slightly and  transiently decreased.  In such instances there was  regularly 
evidence of compound-induced damage in treated uninfected cultures which were observed 
in parallel with the treated or untreated infected cultures. With only a few compounds marked 
reduction in virus-induced cell damage was observed over the course of several days, and no, 
or only very slight, cell changes were observed in treated uninfected cultures. 
On the basis of accumulated experience a criterion of protection was defined. A compound 
was considered capable of protecting cells against the cytopathic effects of a  virus if on any 
day after infection of cultures the extent of cell damage in the presence of some amount of Th~  ~T  AL.  627 
compound in treated infected cultures was 25 per cent or less of that in untreated infected 
cultures. On this basis only two compounds among  the  twenty-five derivatives  examined 
showed  cell-protective activity against viral damage. 
EXPEP rM~,NTAL 
I.  Relationship  between Structure  of Benzimidazole  and Benzotriazole Derivatives 
and Inhibitory Activity on Influenza B and Poliovirus  Type 2 Multiplication 
In chemical inhibition studies with influenza B  virus in the chorioallantoic mem- 
brane and poliovirus type 2 in monkey kidney cells, summarized in Tables I, II, and 
III, the data were expressed as follows: The 75 per cent virus inhibitory concentration 
was designated the virus inhibitory concentration or VIC. Virus inhibitory activity 
relative  to  benzimidazole was  designated  relative inhibitory activity or  RIA.  The 
concentrations causing  2+  macroscopic  changes  in  the  chorioaUantoic  membrane 
or 3 +  microscopic changes in monkey kidney cells were designated toxic concentra- 
tions or TC.  Toxicity relative to  benzimidazole was designated  relative toxicity or 
RT. The ratio of the toxic to virus inhibitory concentration was designated selectivity 
ratio or SR. Selectivity ratio relative to benzimidazole was designated relative selec- 
tivity or RS.  The  abbreviated designations, such  as VIC for virus inhibitory con- 
centration, are  used only in tables and figures. 
With a few derivatives significant protection of cells against virus-induced damage 
was  observed.  Protective activity may be expressed  as  the  molar concentration of 
compound  which  restricts,  under  specified  conditions, the  extent  of  virus-induced 
cell damage in treated  cultures to 25 per cent of that in untreated control cultures. 
The derivatives studied have been grouped on the basis of the position and 
nature of substituents. Within each group compounds are listed in the order of 
their virus inhibitory activity. Most of the compounds  were not completely 
dissolved at inhibitory or toxic concentrations.  All compounds which dissolved 
poorly were  shaken for 1 to 2 hours in protein-free  Eagle's medium (20) at 
35°C. in a mechanical shaker. 
Studies with Influenza  B  Virus.--Results of studies of influenza virus inhibi- 
tory activity and selectivity of action of selected benzimidazole, naphthimida- 
zole, and benzotriazole derivatives are summarized in Tables I and II. 
Group A.--Compounds in Group A may be considered as 5-sulfo derivatives of benzimi- 
dazole. It is of interest that 5-sulfobenzimidazole itself lacked virus inhibitory  activity whereas 
5-sulfonamidobenzimidazole was slightly more active, though not significantly more selec- 
tive, than benzimidazole. Introduction of a methyl group at position 2 reduced the inhibitory 
activity of the 5-sulfonamido derivative. The 5-sulfonanilide  and 5-sulfon-(4-toluldide) deriva- 
fives were considerably more active, but at the same time less selective than benzimidazole. 
Inactivity of 2-(5'-benzimidazolesulfonamido)-thiazole  may have been due to very low solu- 
bility. 
These results indicate that presence of larger substituent groupings at position 5 is fre- 
quently associated with increased inhibitory activity. The dependence of the effect of intro- 
duction of a methyl group at position 2 on the nature of substituents present in the benzenoid 
ring is illustrated by the finding that the 5-sulfonamido-2-methyl derivative was less active TABLE  I 
Influenza B  Virus Inhibitory Activity and Selectivity of Selected Benzimidazole, Naphthimidazole, and 
Benzotriazole Derivatives  in the Chorioallantolc  Membrane in  Vitro 
.o 
Compound 
5 
Z 
1 
5 
6 
7 
8 
9 
10 
Benzimidazole 
derivative 
Benzimidazole* 
5-SulIo 
5-Sulfonamido 
5-Sulfonamido-2-methyl 
2-(5'-Benzimidazolesul- 
fonamido)  -thiazole 
5-Benzimidazolesulfon- 
anilide 
5-B  enzimidazoles  ul  fon- 
(4'-toluidide) 
5-Amino$ 
5- (4'-Toluenesulfon- 
amido)- 
5-  (3',  4'-Dichloroben- 
zenesulfonamido)- 
5- (3',4'-Dichloroben- 
zenesulfoaamido)-  t- 
(3%  4n-dichlorobeazeae  - 
sulfonyl)- 
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R  =  I~S]N  ~-NH- 
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* J. Exp. Med., 1953, 98, 245; J. Boot., 1056, '/2, 41; Virology,  1957, 4, 483. 
SJ. Beet., 1956, 71, 59. 
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Benzimidazole 
derivative 
Compound 
12  5-Fluoro 
Structure 
• 
o~  "~  '~  o  .~ 
,~  .~  o  ~  •~ 
/.~M  /JM 
13  5-Trifluoromethyl 
14  5-Phenyl 
15  5-tert~butyl 
16  5-(a-Methylbutyl)- 
17  5,6-Diisopropyl  202 
13{ 
186 
194  R,~ 
174 
Rt 
R=  188 
18  6-Amino-4-hydroxyben-  265 
zlmidazole  sulfate§ 
19  5-Hydrazino-2-mercapto  180 
20  5- (5 '-Chloro-2 '-hydroxy- 
4'-methylbenzamido)- 
2-mercapto 
21  5- (2'-Cyanoacetyl-5'- 
coumaronesulfon- 
amido)-2-mercapto 
22  5  -[3 '-  (5#-Chloro-2m-hy- 
droxy-4"-methyl- 
phenylcarbamyl)-ben- 
zenesulfonarnido]-2- 
mercapto 
§ Obtained from Dr.  M. Engelman, 
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2,500  1.4  6,400  1.9  2.6  0.7~ 
540  6.5  1,400  8.6  2.6  0.76 
310  11  400  30  1.3  0.38 
850  4.1  960  13  1.1  0.32 
1,500 
1,100  3.2  1,700  7.1  1.5  0.44 
78  45  170  71  2.2  0.65 
2.3  2,200  5.5  1.5  0.44 
1,300  2.7  1,500  8.0  1.2  0.35 
1,100  3.2  1,300  9.2  1•2  0.3~ 
260  13  320  38  1.2  0.35 
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TABLE  I--Continued 
e~ 
I 
Benzimidazole 
derivative 
1-(p-Nitrobenzenesul- 
fonyl)-5,6-dichloro 
1-(m-Nitrobenzenesul- 
fonyl)-5,6-dlchloro 
1-(p-Nitrobenzoyl)-5,6- 
dichloro 
l-(p-Nitrobenzenesul- 
fony[)-2-hydroxy-5,6- 
dichlorobenzimi- 
dazoline 
1- (m-Nitroben~enesui- 
fonyl)-2-hydroxy-5, 6- 
dieh[orobenzimi- 
dazoline 
2-Aminomethyl-5,6-di- 
chloro 
2-(~-Aminoethyi)-L6- 
dichloro 
2-(v-Aminopropyl)-5,6- 
dichloro 
2-Amyl-5-methyl 
2-Heptyl-5-methyI 
Compound 
~3 
372 
372 
336 
390 
390 
216 
230  i 
244 
": a 
Structure  I 
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I 
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R=  [~NO  z 
N 
Cl"~  3  ~2~ R  R  = -CH2NH  2 
H 
R=  --CH  2CH~,NH  2 
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202  v  ~N  R=-CH2CHzCHzCHzCH  3 
I 
I 
2301  R  = --CH2  CH2 CHaCH  2CH2CH2CH3 
570  6.1 
860  4.1 
270  13 
270  13 
73  48 
42  83 
o 
~  g 
30  <2.3  -- 
3,000  4.0  5.3 
I 
1,800 i  6.7  2.1 
600[  20  2.2 
i 
6701  18  2.5 
2t0}  57  2.9 
I 
I 
72 i  1'/0  1.7 
1 
>~ 
1.6 
0,62 
0.65 
0.74 
0.85 
0.50 TABLE 1--Continued 
Compound 
H 
Be~zimidazole 
derivative 
33  2-Hydroxymethyl  148[ 
34  2- (a-Hydroxyethyl)-  16~ 
35  2- (~-Hydroxybenzyl)-  224 
36  2- (a-Hydroxybenzyl) -`5-  259 
chloro 
37  2-(a-Hydroxybenzyl)-  293 
5,6-dichloro 
38  2- (o~Hydroxybenzyl)-  252 
5,6-diraethyl 
39  2-Benzoyl  222 
40  2-Benzyl  208 
41  2-  (p-Aminobenzenes ul- 
fonamido)- 
42  5,6-Dimethyl-l-(0-v- 
rlbofur~nosyl)- 
43  2-Ethyl-,5, 6-dichloro-1- 
~8-D-ribofuranosyl)- 
Naphthlmida~ole 
derivative 
288 
278 
347 
44  Naphth-2, 3-imidazolel[  168 
45  2-Ethylnaphtb-2,  3-  196 
imidazole~ 
I  46  2-Hydroxynaphtb-2, 3-  184 
imidazolel[ 
47  Naph  th-I,  2-imidazole  ~  168 
Structure 
N  OH 
H 
OH 
OH 
OR  CI,~s 
eo  --~H--~  ;  o.d  ¢/~. 
R =  ;  ond 
0 
R= -CH2--  ~ 
O 
R=  --NH--! --~NH  2 
0 
2  R  =  H3C-- 
HCOH 
.¢o~ 7 
HC~ 
dH  2 OH 
R  =  CI--  ;  ond  ~-CH2CH  5  -/ 
N 
H 
R  =  --CH2CH  3 
R=  --OH 
H 
R=  -H 
'-=;I 
•  ~  ,, 
•  ~  ~'~  ~  ~  "=  ,  ,=  +~  "= 
pM  /.tM 
>5,200  <0.67  >5,20C  <2.3 
>`5,300  <0.66  >,5,30C  <2.3 
>3,800  <0.92  >3,80¢  <3.2 
>4,900  <0.71  >4,90(  <2.4  --  -- 
>2,900  <1.2  >2,90(  <4.1  --  -- 
>5,300  <0.66  >5,30(  <2.3  -- 
>8,500  <0.41  >8,500  <1.4  --  -- 
>4,800  <0.73  >4,800 !  <2.5 
>2,700  <1.3  >2,700  <4.4 
2,600  1.3  >2,600  <4.6  >I.0  >0.29 
890  3.9  1,700  7.1  1.9  0.56 
900  3.9  1,300  9.2  1,4  0.41 
>3,500  <1.0  >3,,500  <3.4 
>3,,500  <1.0  >3,,500  <3.4 
370  9.5  790  1,5  2.1  O. 62 
Obtained from Dr. D. J. Brown, The Australian National University, Canberra. 
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Compound 
Benzotriazole 
d  derivative 
48  Benzotriazole 
49  5-Chloro 
50  5,6-Dichtoro 
51  4,5,6-Trichloro 
82  4,5,6, 7-Tetrachloro 
83  5-Fluoro 
54  5-Trifluoromethy! 
55  5,6-Dimethyl 
119 
154 
188 
223 
25~ 
137 
187 
147 
56  6-Amino-4-hydroxybenzo  223 
triazole dihydrochlo- 
ride§ 
57  5-Hydroxybenzotriazole-  179 
4-carboxyllc acid¶ 
38  5-Hydroxybenzotriazole-  188 
6-carboxylic  acid¶ 
59  5-Hydrox3rbenzotriazole -  254 
6-carboxanilide¶ 
Structure 
R  N 
"FfY  N  R=. 
H 
R:  CI -- 
R  =  Cl-;  ond  CI/j'~'~ 
R-"  Cl- ;  and  6 
c~)-~.~ 
Ct 
R  =  El-;  and  ~'~-~ 
Ct] 
CI 
R =  F- 
F 
I 
R=  F-C-- 
I 
F 
R =  H3C-;  and  16 
OH  / 
R=  H--  ;  and 
& 
H2N  ~  -2 HCI 
R 
o. 
H 
R=  H--;and  ?A 
HO-C i/2  1"t20 
60  5-Hydroxybenzotriazole-  304  R=  [.  []  _1 
4-earboxy-~-naph thyl- 
amide ¶  N  H 
I 
C=O 
I 
CI 
61  4-(p-Chlorophenylazo)-  274,  R=  () 
5-hydroxybenzotri- 
azole¶  I J 
II 
N 
I 
O~ 
~ 
..~  80" 
.~.~  -~ 
NM  /~M 
7,500  0.47  11,000 
610  5.7  860 
54  65  100 
12  290 
I 
3  11,200  i 
! 
2,600  1.3  5,100 
180  19  400 
>-5,300  <(0.66  >-5,300 
1.1 
14 
120 
44  270 
9 1,300 
1,400  2.5  2,500 
r~ 
1.5 
1.4 
1.9 
3.7 
3.0 
2.4  2.0 
30  2.2 
<(2.3 
4.8 
:E 
~v 
L 
0.44 
i 
0.41 
r 
i 
i 
0.56 
1.1 
0.88 
0.59 
0,65 
1.8  0.53 
7,200  0.49  9,200  1.3  1.3  0.38 
0.52  9,000  1.3  1.3 
2.9  i  1,600  7.5  1.3 
3.1 
6,700 
1,200 
40  300 
I 
I  19  630 
i 
3  270 
i 
I 
! 
I 
4.3  810 
! 
4.4 
0.38 
0.38 
i 
0.91 
r 
1  I 
k 
I 
1.3 
¶  Obtained from Dr. F. H. Adams, American Cyanamid  Company,  Bound  Brook, New Jersey. 
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TABLE~I Continued 
633 
~D 
Compound 
Benzotriazole  ~  Structure 
derivative 
I o.I 
CI  ~  N  H  C"--'-I  62  1-(a-D-Ribofuranosyl)-  320  ~'~Y'%zN  R: 
5,6-dichloro  C  i  ~7.,...~.,.,~  i~1  /  HCOHI  I  0 
R  Hi~.___J 
I 
i/H  CH20H 
I  63  1- (fl-D-Ribofuranosy]) -  320  R=  HCOH 
5,6-dichloro  I  0  HCO"  I 
HC 
I 
CH20H 
64  2-(O~-D-Ribofuranosyl)-  32£  N R  R=-C-C-C-C-CH2OH 
5,6-dichloro  Cl  ~.,,,~1/  H  /  H  H 
H 
65  2-(fl-v-Ribofuranosyl)-  32C  R=  --C- C- C- C- CH20H 
5,6-dichloro  H  H 
8  o  ~  ~  o  .~, 
,..a.o  .~ ~  .~.  "-  .~ 
~o  +.~ 
I,  2.3  2,100  5.7  1.4  0.41 
4.7  1,400  8.6  1.9  0.5( 
6.4  1,100  11  2.0  0.5~ 
4.2  800  15  0.96  0.2~ 
than  5-sulfonamidobenzimidazole. It was  found earlier that  whereas such introduction  de- 
creased  the inhibitory  activity of 5,6-dichloro-l~-D-ribofuranosylbenz~m~dazole  (2),  it in- 
creased  the  activity  of  5-methyl,  4,5-dimethyl,  5,6-dimethyl,  and  5-chlorobenzimidazole 
(1, 2). 
Group B.--Compounds in this group may be considered to be 5-amino derivatives of ben- 
zimidazole.  5-Aminobenzimidazole itself was  inactive  (21);  in  contrast,  the  toluenesulfon- 
amido and  dichiorobenzenesulfonamido derivatives were highly active. The  toluenesulfon- 
amido derivative was  less selective whereas  the dichlorobenzenesulfonamido derivative was 
more  selective than  unsubstituted  benzimidazole.  The  inhibitory activity of  the  dichloro- 
benzenesnlfonamido derivative was further increased by introduction of a  second dichloro- 
benzenesulfonyl group at position 1. 
These results lend further support to the contention that the presence of large substituents 
at position 5 is associated with high inhibitory activity. Comparison of the structures  and 
activities of 5-be, z~midazolesulfon-(4'-toluidide)  and 5-(4'-toluenesulfonamido)-benzimidazole 
reveals a  13-fold difference in activity in favor of the latter.  As can be seen in Table I, the 
only structural  difference between these compounds involves the sulfonamido link between 
the ber~imidazole and toluene ring structures. 
Group  C.--This group  includes five compounds with different substituents  attached  to 
position 5, and two compounds with two substituents in the benzenoid ring. It is of interest 
that  the  5-trifluoromethyl  derivative was  more  active than  the  5-fluoro  compound.  The 634  VIRUS  INHIBITORY  ACTIVITY  OF  BENZIMIDAZOLES 
5-phenyl,  5-tert-butyl,  and  5-(a-methylbutyl)  derivatives were  compounds  of  moderate  to 
high virus inhibitory activity. The 5,6-diisopropyl and 6-amino-4-hydroxy derivatives were 
also considerably more active than benzimidazole. All compounds in  this group  were  less 
selective  than  benzimidazole. 
These results, too, support the contention that substitution of larger groups at position 5 
causes a marked increase in virus inhibitory activity. 
Group D.--Each of the four derivatives of 2-mercaptobenzimidazole included in this group 
has a different substituent at position 5. These substituents range from the relatively simple 
hydrazino group  to the complex 3-(5'-chloro-2'-hydroxy-4'-methylphenylcarbamyl)-benzene- 
sulfonamido grouping. All four derivatives showed similar low virus inhibitory activity, which 
may be due to the presence of the mercapto group at position 2 or to the nature of the sub- 
stituents at position 5. The selectivity of these derivatives was also low. 
Group E.--In this group are included three derivatives of 5,6-dichlorobenzimidazole and 
two derivatives of 2-hydroxy-5,6-dichlorobenzimidazoline. The first three compounds were 
inactive. Since 5,6-dichlorobenzimidazole itself is approximately fourteen times more active 
than benzimidazole (2), the failure of the 1-nitrobenzenesulfonyl and 1-nitrobenzoyl deriva- 
tives to inhibit influenza virus multiplication may be due to a possible inactivating effect of 
these substitutions at position 1.  Similar observations with other derivatives have been re- 
ported previously (2). The 1-(p-nitrobenzenesulfonyl) and 1-(m-nitrobenzencsulfonyl) deriva- 
tives of 2-hydroxy-5,6-dichlorobenzimidazoline were of low activity, but the meta compound 
was  1.6 times more selective than benzimidazole. 
Group F.--Five compounds are included and each has a  different substituent at position 
2.  The first three are derivatives of 5,6-dichlorobenzimidazole. Introduction of the amino- 
methyl group reduced the inhibitory activity of 5,6-dichlorobenzimidazole (2)  to 1~ whereas 
introduction of either the fl-aminoethyl or 'y-aminopropyl group had no effect on inhibitory 
activity, but increased the solubility of  the  compounds. 
Both the 2-heptyl-5-methyl and the 2-amyl-5-methyl derivatives were highly active, with 
the  2-heptyl-5-methyl compound  being two  times  more  active  than  the  2-amyl-5-methyl 
derivative. This is of interest because in earlier studies it was found that although the 2-ethyl- 
S-methyl derivative was considerably more active than the 2,5-dimethyl compound, further 
lengthening of the alkyl side chain at carbon 2 by one or two alkyl residues (giving propyl 
and butyl derivatives) did not increase inhibitory activity (1). 
All five new derivatives were less selective than unsubstituted benzimidazole. 
Group G.--This group includes an additional series of nine derivatives substituted at posi- 
tion 2.  None of these compounds showed inhibitory activity on influenza virus multiplica- 
tion. As is reported below, two of these compounds, i.e. 2-(oz-hydroxybenzyl)-benzimidazol¢ 
and its 5-chloro and 5,6-dichloro derivatives, are active as inhibitors of poliovirus multipli- 
cation  and  cytopathogenicity. 
It was found earlier that 5-methyl-2-D-ribobenzimidazole and certain other polyhydroxy- 
alkyl derivatives of benzimidazole increase the yield of influenza virus in the chorioallantoic 
membrane (10, 11, 18). It appeared on the basis of these studies that the presence of hydroxyl 
groupings was the essential structural feature of position 2 substituted compounds with en- 
hancing activity.  The  present  finding  that  the  2-hydroxymethyl and  2-(a-hydroxyethyl) 
derivatives possess no enhancing activity indicates that a  single hydroxyl group is not suffi- 
cient to impart such activity. 
Group //.--Two  1-/3-D-ribofuranosyl  derivatives are included: the 5,6-dimethyl and  the 
2-ethyl-S,6-dichloro compounds. Both showed low inhibitory activity and selectivity. 
5,6-Dimethyl-l-(fl-D-ribofuranosyl)-benzimidazole  differs from the benzimidazole riboside 
moiety in vitamin BI~ only in that the ribose moiety is in the/3 rather than a  linkage. It was 
shown  earlier  that  the a-linked  ribofuranoside of  5,6-dimethylbenzimidazole possesses  no TA~mE~Z  AL.  635 
influenza virus inhibitory activity (2).  In contrast,  the 5,6-dichloro derivative of ~-D-ribo- 
furanosylbenzlmldazole is 92 times more active and  2.4 times more selective than benzimi- 
dazole (2). Thus, for high activity the presence of chlorine rather  than methyl substituents 
in the benzenoid ring appears essential.  Certain other halogen derivatives of E-linked ribo- 
furanosylbenzimidazole have also been examined and found to be highly active (5). 
The fact that introduction of an ethyl group at position 2 of the 5,6-dichloro-l-~-D-ribo- 
furanosyl compound lowered its inhibitory activity to ~8 is in line with the earlier observa- 
tion that introduction of a methyl group reduced the activity to ~.5 (2). These findings pro- 
vide a contrast to the observation that such substitution increases the inhibitory activity of 
derivatives containing alkyl substituents in the benzenoid ring (1). 
Group/.--Four naphthimidazole compounds are included. The parent compound, naphth- 
2,3-imidazole was of low activity and selectivity. Substitution of an ethyl or hydroxy group 
at position 2 inactivated the compound.  Naphth-l,2-imidazole was 2.4 times more active 
than naphth-2,3-imidazole, but it, too, showed low selectivity. These findings  parallel some 
of the observations with benzimidazole derivatives. 
Group J.--This group includes benzotriazole and four derivatives with one to four chlorines 
in the benzenoid ring. Benzotriazole was only one-half as active as benzimidazole. However, 
with each chlorine introduced  the activity increased markedly.  4,5,6,7-Tetrachlorobenzo- 
triazole was the most active compound among the sixty-five included in Table I. It caused 
75 per cent inhibition of influenza virus multiplication at a  concentration of 3.0 X  10-e 
or 0.8 gg./ml. The selectivity of the tri- and tetrachloro derivatives was similar to that of 
benzimidazole. Benzotriazole, and the mono- and dichloro derivatives were less selective. 
The series of four chloro derivatives of benzotriazole provides a  striking example of de- 
pendence of high virus inhibitory activity on multiple substitution  in the benzenoid ring. 
Benzotriazole itself was  less  active than  benzimidazole and  the monoehloro derivative of 
benzotriazole was only 1.2 times more active than the corresponging benzimidazole, but the 
di-,  tri-,  and  tetrachloro  derivatives of benzotriazole were approximately  five times more 
active than  the corresponding  benzimidazoles.  Furthermore,  the benzotriazole derivatives 
were considerably more soluble at pH 7.2 in the medium used. 
Group K.--This group includes two benzotriazole derivatives substituted  at position 5, 
and  two others which have two substituents  in the benzenoid ring. The 5-trifluoromethyl 
compound was much more active than the 5-fluoro  derivative, but both were less  selective 
than  benzimidazole.  5,6-Dimethylbenzotriazole  was  inactive  and  the  6-amino-4-hydroxy 
compound showed low activity and low selectivity. 
The potentiating effect on inhibitory activity of introduction of larger groups is strikingly 
illustrated by the  15-fold  difference in activity between the 5-trifluoromethyl and  5-fluoro 
derivatives. Failure of 5,6-dimethylbenzotriazole to inhibit may be due to low solubility or 
intrinsic inactivity of the compounds. 
Group L.--All of the benzotriazole derivatives in this group possess  an hydroxyl group at 
position 5.  In addition,  each compound has a  second substituent  at either position 4 or 6. 
The  carboxylic acid  derivatives of  5-hydroxybenzotriazole showed  very low activity and 
selectivity. The 6-carboxanilide derivative was  2.9  times more active than  benzimidazole, 
but it, too, was non-selective. In contrast, the 4-carboxy-a-naphthylamide was very highly 
active, and in selectivity of action it was similar to benzimidazole. The 4-(p-chlorophenylazo) 
compound was even more active, and it was slightly more selective than the reference com- 
pound. 
The 4-carboxy-ot-naphthylamide  and  4-(p-chlorophenylazo)  derivatives provide striking 
examples of correlation between presence of large substituents in the benzenoid ring and high 
virus inhibitory activity. The low activity of the 6-carboxanilide derivative is noteworthy, 
because it suggests that the position of the substituent in the benzenoid ring may be impor- 636  VIRUS INHIBITORY ACTIVITY OF  BENZIMIDAZOLES 
tant. Earlier work showed (1) that introduction of methyl groups at positions 4 and 5 of the 
benzenoid ring cumulatively  increased the inhibitory  activity of benzimidazole derivatives; 
in contrast, introduction of a methyl group at position 6 did not cause an increase in activity. 
Group M.--This group includes four D-ribofuranosyl derivatives of 5,6-dichlorobenzotri- 
azole. All four compounds showed low virus inhibitory activity and selectivity. The fact that 
substitution  of the D-ribofuranose moiety in fl-linkage at position 1 resulted in marked inac- 
tivation  rather than in potentiation  of the inhibitory  activity of 5,6-dichlorobenzotriazole 
is surprising because the fl-D-ribofuranosides of six halogenated benzimidazoles were all more 
active than the corresponding parent compounds without  the ribofuranosyl moiety (2, 5). 
This provides another  example of the dependence of the effect of a substituent  not only on 
its own nature and position, but also on the structural  characteristics of other parts of the 
molecule. 
Summary  of Influenza  Virus  Inhibitory  Activity  and Selectivity  of Certain 
Benzimidazole,  Naphthimidazole,  and Benzotriazole Derivatives. In Table II the 
compounds studied are listed in order of their influenza virus inhibitory activity. 
As  can  be  seen,  a  considerable  number,  i.e.  eighteen,  showed  no  detectable 
inhibitory  activity  and  four  additional  compounds  were  less  active  than 
benzimidazole.  Forty-three derivatives  were more active  than  benzimidazole. 
The most active derivative, 4,5,6, 7-tetrachlorobenzotriazole,  was  1200 times 
more active than the reference compound; however, it was slightly less selective 
than  benzimidazole. 
Three  compounds,  5-sulfonamidobenzimidazole,  5-hydroxybenzotriazole-4- 
carboxy-ot-naphthylamide,  and  4,5,6-trichlorobenzotriazole  were  closely 
similar  to benzimidazole in selectivity of action. The relative virus inhibitory 
activities of these compounds were 1.3, 270, and 290 respectively. 
Only four compounds showed somewhat greater selectivity than benzimida- 
zole;  1-(m-nitrobenzenesulfonyl)-2-hydroxy-5,6-dichlorobenzimidazoline,  5- 
(3',4  ~- dichlorobenzenesulfonamido)  -  benzimidazole,  5  -  (3',4' -  dichloroben- 
zenestflfonamido)-l-(3tt,4PP-dichlorobenzenesulfonyl)-benzimidazole,  and  4-(p- 
chlorophenylazo)-5-hydroxybenzotriazole.  The  relative  virus  inhibitory 
activities of these compounds were 6.1, 350, 560, and 810, respectively. Thus, 
most of the  compounds studied  were  less  selective  than  benzimidazole,  and 
none was highly selective. 
Studies with Poliovirus  Type 2.--Of the sixty-five benzimidazole, naphthimi- 
dazole, and benzotriazole derivatives studied with influenza virus in the chorio- 
allantoic membrane,  twenty-five were investigated with poliovirus in monkey 
kidney  cells.  The  results  of studies  of the  relationship  between  structure  of 
these selected compounds and their poliovirus inhibitory activity and selectivity 
are  summarized  in Table  III. To facilitate  cross-reference,  compounds listed 
in Table III are referred to by the same numbers as were used in Tables I  and 
II. 
Group A.--The poliovirus inhibitory activity of 5-sulfonamidobenzlmidazole was  similar 
to that of the reference compound, but the sulfonamldo derivative was approximately  twice TABLE II 
Activities and Selecti¢ities  of Benzimldazole,  NaOhtkimidazole,  and Benzogriazol¢ Derivali¢es as Inhibilors of 
Influenza B  Virus Multiplication 
No. 
1 
2 
5 
8 
23 
24 
25 
33 
34 
35 
36 
37 
38 
39 
40 
41 
45 
46 
55 
48 
57 
58 
4 
3 
42 
53 
12 
19 
62 
56 
20 
59 
21 
22 
43 
44 
18 
28 
65 
26 
63 
49 
27 
64 
13 
47 
17 
14 
15 
29 
30 
7 
54 
6 
16 
31 
50 
32 
9 
60 
51 
10 
11 
61 
82 
Derivative 
Benzimidazole 
5-Sulfobenzimidazole 
2- (5'-BenzimidazolesulfonaInido)-thiazole 
5-Amlnobenzimidszole 
1- (p-Nitrobenzenesulfonyl)-5,6-dichlorobenzimidazole 
1  - (m-Nitrobenzenesulfonyl)-5,6-dichlorobenzlmidazole 
1- (p-Nitrobenzoyl)-5,6-dichlorobenzimidazole 
2-Hydroxymethylbenzimldazole 
2-(~-Hydroxyethyl)-benzimidazole 
2-(a-Hydroxybenzyl)-benzimidazole 
2- (a-Hydroxybenzyl)-5-chlorobenzimidazole 
2- (a-Hydroxybenzyl)-5,  6-dichlorobenzimidazole 
2- (a-Hydroxybenzyl)-5,6-dimethylbenzimidazole 
2-Ben zoylbenzlmidszole 
2-B  enzylbenzimidazole 
2- (p-Amlnobenzenesulfonamido)-beuzimidazole 
2-Ethylnaphth-2,5-imidazole 
2-Hydroxynaphth-2, 3-imicbtzole 
5,  6-Dimet  hylbenzotrlazole 
Benzotriazole 
5-Hydroxybenzotrlazole-4-carboxyllc  acid 
5-Hydroxybenzotriazole-6-carboxylic  acid 
5-Sulfonamido-2-methylbenzlmidazole 
5-Sulfonamidobenzimldazole 
5,  6-Dimethyl-1-  ~8-D-ribofuranosyl)-benzhnidazole 
5-Fhiorobenzot  riazole 
5-Fluorobenzimidazole 
5-Hydrazlno-2-mer  captobenzlmidazole 
I-  (a-~-Ribofuranosyl)-5,6-dlchlorobenzotriazole 
6-Amino-4-hydroxybenzotriazole dihydrochloride 
5-  (5'-Chloro-2'-hydroxy-4'-methylbenz~mldo)-2-mercaptobenzimidazole 
5-Hydroxybenzot  rlazole-6-carboxanilide 
5- (2'-Cysnoacetyl-5  '-coum~ronesulfonamldo)  -2-mercaptobenzimidazole 
5-[Y-(5"-Chloro-2"-hydroxy-4"-methylphenylcarbamyl)-benzenesulfona- 
mido]-2-mercaptobenzJm|dazole 
2-Ethyl-5, 6-dichloro-l-  (~-n-ribofuranosyl)-benzimidazole 
Naphth-2,3-imldazole 
6-Amino-4-hydroxybenzlmidazole  sulfate 
2-Aminomethyl-5,  6-dich]orobenzimidazule 
2- (~-n-Ribofuranosyl)-5,  6-dichlorobenzotriazole 
I-  (p-Nitrobenzenesul  fonyl) -2-hydroxy-5, 6-dlchlorobenzimidazoIine 
1  - (~-v-Ribofuranosyl)-5,6-dlchlorobenzotriszole 
5-Chlorobenzot riazole 
I-  (m-Nitrobenzenesul fonyl)-2-hydroxT-5, 6-dichlorobenzimldazoline 
2- (a-v-Ribofuranosyl)-5,6-dichlorobenzot  riazole 
5-Trifluoromethylbenzimidazole 
Naphth-l, 2-imidazole 
5,6-Diisopropylbenzimidazole 
5-Phenylbenzlmidazole 
5-tert-butylbenzimidazole 
2-(~-Amlnoethyl)-5,6-dichlorobenzimidazole 
2- (7-AminoproPyl)-5,  6-dichlorobenzimidazole 
5-Benzimidazolesulfon-  (4'-toluidide) 
5-Trifluoromethylbenzot  riazole 
5-Benzlmidszolesulfonanillde 
5- (a-Methylbutyl)-benzlmidszole 
2-Amyl-5-methylbenzlmidazole 
5,6-Dicblorobenzotrlazole 
2-Heptyl-5-methylbenzlm|  dszole 
5- (4'-Toluenesulfonamldo)-benzimidazole 
5-Hydroxybenzotxiazole-4-carboxy-a-naphthylamlde 
4, 5, 6-Trichlorobenzotriazole 
5- (Y, 4  '-Dichlorobenzenesul  fonsmido)-benzimldazole 
t  0  t  H  5-(3,4-Dichlorobenzenesulfonamido)-l-(Y ,4  -dlchlorobenzenesulfonyl)- 
benzimidszole 
4- (p-  Chlorophenylazo)-5-hydroxybenzotriazole 
4,5,6, 7-Tetrachlorobenzotriazole 
Inhibitory 
activity 
relative to 
benzimidazole 
1.0 
<0.35 
<1.8 
<1.0 
<0.66 
<0.66 
<0.66 
<0.67 
<0.66 
<0.92 
<0.71 
<1.2 
<0.66 
<0.41 
<0.73 
<1.3 
<1.0 
<1.0 
<0.66 
0.47 
0.49 
0.52 
0.60 
1.3 
1.3 
1.3 
1.4 
2.3 
2.3 
2.5 
2.7 
2.9 
3.2 
3.2 
3.9 
3.9 
4.1 
4.1 
4.2 
4.3 
4.7 
5.7 
6.1 
6.4 
6.5 
9.5 
11 
12 
13 
13 
13 
19 
19 
23 
45 
48 
65 
83 
250 
270 
290 
350 
560 
810 
1200 
Selectivity 
relative to 
benzi- 
midazole 
1.0 
0.44 
0.38 
0.38 
;>0.35 
1.1 
;>0.29 
0.59 
0.76 
0.44 
0.41 
0.53 
0.35 
0.38 
0.35 
0.44 
0.56 
0.41 
0.32 
0.62 
0.28 
>0.68 
0.56 
0.41 
1.6 
0.59 
0.76 
0.62 
0.38 
0.32 
0.35 
0.65 
0.74 
0.65 
0.65 
0.56 
0.65 
0.85 
0.56 
0.50 
0.59 
0.91 
1.1 
2.4 
2.1 
1.3 
0.88 
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as  selective.  Both  the  sulfonanilide  and  sulfon-(4-toluidide)  derivatives  were  moderately 
active,  and  the  latter  also showed  increased  selectivity.  Except  for  some  minor  differences, 
TABLE  III 
Polio~irus Type 2 Inhibitory Activity and Sdectivity of Benzimidazole and Benzotriazole 
Derivatives in Monkey Kidney Cells in Vitro 
Compound 
Group No. I  Benzlmidazole derivative 
A 
K 
9 
10 
11 
29 
30 
31 
33 
34 
35 
36 
37 
38 
39 
40 
48 
49 
50 
81 
52 
54 
75 per  Rela- 
cent viru.,  tire 
inhibitory  hahibi- 
concen-  tory 
tration  activity 
(VIC)  (RIA) 
3+ 
toxic  Relative  Selec-  Relative 
concen-  toxicity  tivity  selec-  ratio  tivity 
trafion  (RT)  (SR)  (RS) 
¢rc) 
t*M  t*M 
Benzlmidazole  2800  1  5200  1  1.9  1 
5-Sulfonamido  2400  1.2  >8800  <0.59  >3.7  >1.9 
5-Benzimidazolesulfonanilide  130  22  > 270  < 19  > 2.1  > 1.1 
5-Benzlmldazolesulfon-  (4'-  toluidide)  96  29  >400  >13  >4.2  >2.2 
5- (4'-Toluenesulfonamido)-  21  130 
5-(3 ~, 4'-Dichlorobenzenesulfonamldo)-  12  230 
3- (3t, 4~-Dichlorobenzenesulfonamido)-I  - 
(3",4"-dichlorobenzenesulfonyl)-  10  280 
5-Trifluoromethyl 
>60  <87  >2.9  >1.5 
>100  <52  >8.3  >4.4 
2-Amhaomethyl-5,  6-diehloro 
2-(a-Aminoethyl)-5,  6-dichloro 
2-  (3,-Aminopr  opyl)-5, 6-dichloro 
>100  <52  >10  >5.3 
350  8.0  >450  <12  >1.3  >0.68 
130  22  950  55  7.3  3.8 
,'.-.60  ~47  ~60  ~87  ~1  ~0.53 
~60  ~47  ~60  ,'-.87  ~1  ~0.53 
2-Hydroxyraethyl  >3800  <0.74  >3800  <1.4  --  -- 
2-(a-Hydroxyethyl)-  >3500  <0.80  >3500  <1.5  --  -- 
2- (~-Hydroxybenzyl)-  36  78  >1100  <4.7  >31  >16 
2- (a-Hydroyxbenzyl)-5-chloro  22  130  >640  <8.1  >29  >15 
2- (a-Hydroxybenzyl)-5,  6-diehloro  140  20  > 1300  <4.1  > 9.1  >4.8 
2-(ot-Hydroxybenzyl)-5,6-dimethyl  740  3.8  >1000  <5.2  > 1.4  >0.74 
2-Benzoyl  740  3.8  >1100  <4.7  >1.5  >0.79 
2-Benzyl  95  29  >360  <14  >3.8  >2.0 
Benzotriazole derivative 
Benzotriazole  2800  1  11000  0.47  3.9  2.1 
5-Chloro  500  5.6  1600  3.3  3.2  1.7 
5,6-Dichloro  73  38  260  20  3.6  1.9 
4,5,6-Triehloro  23  120  50  100  2.2  1.2 
4,5,6,7-Tetrachloro  8.1  350  12  430  1.5  0.79 
5-Triltuoromethyl  240  12  >450  12  1.9  1.0 
the inhibitory activity and selectivity of action of compounds in this group were similar with 
influenza  and  poliovirus. 
Group  B.--The  toluenesulfonamido  and  dichlorobenzenesulfonamido  derivatives  were 
highly active,  and  showed  increased  selectivity.  The  activity  and  selectivity  of compounds 
in this group were similar with influenza and poliovirus. 
Group C.--5-Trifluoromethylbenzimidazole  was  eight  times  more  active,  but  not  more TA~XT  AL.  639 
selective than the reference compound. Similar results were also obtained with influenza virus. 
Group F.--The 2-aminomethyl-5,6-dichloro derivative was one-half as active, but several 
times more selective than the corresponding 2-fl-aminoethyl and 2-~/-aminopropyl  compounds, 
which appeared to be considerably more toxic for monkey kidney cells than for the chorioal- 
]antoic membrane. All three derivatives were more active against poliovirus in monkey kidney 
cells than against influenza virus in the chorioailantoic membrane. 
Group  G.--From  the  viewpoint of selective inhibition  of poliovirus  multiplication  this 
group contains derivatives of greatest interest. Of the six compounds which possessed  inhibi- 
tory activity on poliovirus multiplication, three were of sufficiently low  toxicity so that at 
virus inhibitory concentrations only slight or no microscopic cell changes due  to compound 
were seen at 48 hours. Two of the three, i.e. 2-(o~-hydroxybenzyl)-benzimidazole  (HBB) and 
the 5-chloro derivative of H.BB, were also capable of causing marked inhibition of the cyto- 
pathic  effects of poliovirus, as is shown  below.  The third  compound, i.e. the  5,6-dichloro 
derivative of HBB, was much less active as an inhibitor of poliovirus multiplication and cyto- 
pathic effects than either the parent molecule or the 5-chioro  derivative. 
The data  on structure-activity relationships summarized in Table  Ill indicate that the 
hydroxybenzyl grouping at position 2 is of fundamental  importance for the selective virus 
inhibitory action of HBB. As can be seen in Table III, the 2-hydroxymethyl and 2-(a-hydroxy- 
ethyl) derivatives of benzimidazole were inactive, and  the  2-benzoyl and  2-benzyl deriva- 
tives showed low selectivity although they were slightly to moderately active. 
Compared to HBB or its 5-chloro derivative, the low activity and selectivity of the 5,6- 
dimethyl derivative are striking. This observation and  the finding that the activity of the 
5,6-dick[oro derivative was also relatively low, indicate that introduction of chloro or methyl 
substituents at both the 5 and 6 positions is undesirable from the viewpoint of virus inhibi- 
tory  potency  and  selectivity. 
It should be emphasized that none of the compounds in group G showed any inhibitory 
activity with influenza B virus in the chorioallantoic membrane. HBB was also studied with 
influenza virus in monkey kidney cells, and, as is reported below, no inhibition of virus yield 
or virus-induced cell damage was observed. 
Group J.--Benzotriazole was equal in activity to benzimidazole. The chloro derivatives 
which contained one to four chlorine atoms in the benzenoid ring were progressively more 
active as the number of substituents was increased. However, the highly active tri- and tetra- 
chloro derivatives were less selective than benzotriazole or the mono- and dichloro derivatives. 
Benzotriazole showed  greater  activity with poliomyelitis than  influenza virus,  whereas 
with the tri- and tetrachloro derivatives the reverse was true. The mono- and dichloro deriva- 
tives showed similar activity with the two viruses. With respect to selectivity, benzotriazole 
and the mono- and dichloro derivatives were all somewhat more selective in inhibiting polio- 
myelitis than  influenza virus multiplication.  No striking  differences  were observed in  this 
respect with the two viruses and tri- and tetrachloro derivatives. 
Group K.--The 5-trifluoromethyl compound was twelve times more active, but not more 
selective than benzimidazole. Similar results were obtained with influenza virus. 
Summary of Poliovirus Inhibitory Activity and Selectivity of Certain Bemimi- 
dazole and Benzotriazole Derivatives.--Of  the  twenty-five  compounds  studied, 
two  lacked  poliovirus  inhibitory  activity  and  the  activity  of  another  was 
similar  to  that  of  benzimidazole.  Twenty-one  derivatives  were  more  active 
than the reference compound. The most active derivative, 4,5,6,7-tetrachloro- 
benzotxiazole,  was 350  times more active  than  the reference  compound;  how- 
ever,  it  was  slightly  less  selective  than  benzimidazole.  Several  compounds 640  VIRUS  INHIBITORY  ACTIVITY  OF BENZI~{IDAZOLES 
were  similar  to  benzimidazole in  selectivity of action,  or showed somewhat 
greater selectivity. 
Two compounds stood out in that they were both much more active and 
selective than benzimidazole. 2-(a-Hydroxybenzyl)-benzimidazole (HBB) and 
2-(cz-hydroxybenzyl)-5-chlorobenzimidazole showed  78 and  130  times greater 
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TExT-Fzo. I. Inhibition of multiplication and cytopathic effects of poliovirus type 2 by 
2-(~-hydroxybenzyl)-benzimidazo]e (HBB), and toxicity of the compound in monkey kidney 
cells. 
activity, respectively, and more than 15-fold greater selectivity than benzimi- 
dazole. These compounds,  and  also  the  5,6-dichloro derivative of HBB  are 
discussed below. 
Inhibition of Poliovirus Multiplication  and Cytopathic Effects by 2-(a-ttydroxy- 
benzyl)-benzimidazole (ttBB), and Its 5-Chloro and 5,6-Dichloro Deriratives.-- 
Of the twenty-three benzimidazole and benzotriazole derivatives which were 
capable of inhibiting the yield of poliovirus in monkey kidney cells only two, 
i.e. 2-(a-hydroxybenzyl)-benzimidazole (HBB), and the 5-chloro derivative of TAMM  ET  AL.  641 
HBB, showed significant protective activity against virus-induced cell damage, 
as illustrated in Text-figs. 1 and 2.  The 5,6-dichloro derivative of HBB did 
not reproducibly cause 75  per cent inhibition of viral cytopathic effects (d. 
Text-fig. 3). It should be emphasized that neither HBB nor its chloro deriva- 
tives were completely dissolved at the higher concentrations employed. 
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T~xT-FIo. 2. Inhibition of multiplication and cytopathlc effects  of poliovirus type 2 by 
2-(a-hydroxybenzyl)-5-chlorobenzimidazole,  and toxicity of the compound  in monkey  kidney 
cells. 
The upper parts of Text-figs. 1 to 3 show curves relating compound-induced 
cell damage, and inhibition of virus yield and virus-induced cell damage, to 
concentration of HBB and its derivatives. All determinations were carried out 
at  48  hours.  The  lower parts  show  time  curves  of  compound-induced cell 
damage. 
With HBB, the curves describing the relationship between concentration of 
compound  and  inhibition  of  virus  yield or  reduction  in  virus-induced  cell 642  VIRUS  INHIBITORY  ACTIVITY  OF  BENZIMIDAZOLES 
damage were approximately parallel.  At a  concentration  of  190  #M,  all cells 
appeared protected. Over the greater part of the concentration range studied, 
no  compound-induced  cell changes  were  observed in uninfected  cultures.  At 
493 #M, which was the highest concentration used,  slight cell changes due to 
compound were observed. The time curves of compound-induced cell damage 
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TEXT-FIo. 3. Inhibition of multiplication and cytopathic effects of poliovirus type 2 by 
2-(a-hydroxybenzyl)-5,6-dichlorobenzimidaaole, and  toxicity of the  compound in  monkey 
kidney cells. 
show that even at 493  t~  the extent of HBB-induced cell changes increased 
only slightly on prolonged incubation. 
With  the  monochloro derivative,  the  curves describing  inhibition  in  virus 
yield  and  reduction  in  virus-induced  cell  damage  were  also  approximately 
parallel.  At  a  concentration  of 85  #~  all  cells  appeared  protected,  but  the 
monochloro derivative caused definite toxic effects at the higher concentrations. 
Compound-induced cell changes were observed in 48 hours,  and they became 
marked as incubation was continued. TAM~ ~T A~.  643 
With both HBB and its 5-chloro derivative the concentrations at which 75 
per cent reduction in virus-induced cell damage was observed were 1.5 times 
higher than those sufficient to cause 75 per cent reduction in virus yield. 
With the dichloro derivative, the curve relating reduction in virus-induced 
cell damage to concentration of compound deviated considerably from that 
describing the relationship between concentration and inhibition in virus yield, 
and,  regardless  of  concentration,the  highest  degree  of  protection  observed 
was only 60 to 80 per cent. It should be emphasized that this compound was 
much less active than the other two in inhibiting the yield of virus. As with 
the monochloro derivative, significant cytotoxic changes were observed at the 
higher concentrations. These  changes became  marked when incubation was 
continued for a period of 6 to 7 days. 
The results obtained suggest that reduction in poliovirus-induced cell damage 
was  due  to  inhibition of  the  viral reproductive process.  This  conclusion is 
supported by results obtained with influenza B virus in monkey kidney cells. 
HBB  not only failed to  inhibit the multiplication of influenza virus,  but it 
also had no significant protective  effect against influenza virus-induced  cell 
damage. 
Progression of Compound-Induced Cell Damage.--The  time curves of com- 
pound-induced cell damage obtained with 20 benzimidazole and benzotriazole 
derivatives lacking protective activity against poliovirus-induced cell damage 
are shown in Text-figs. 4 and 5. Each of these 20 compounds reduced the yield 
of poliovirus, but showed low selectivity. 
With most compounds increase in cell damage was gradual with time, and 
observations made at 48 hours were representative of the total time course of 
toxic  phenomena,  particularly  at  lower  concentrations  of  the  compounds. 
However, with a few compounds, a rather abrupt increase in microscopic cell 
damage was observed after the 2nd day, particularly at higher concentrations. 
Poliovirus  Inhibitory Activity  of  Certain Benzimidazole Derivatives.--In 
earlier studies of the effects of selected benzimidazole derivatives on influenza 
B virus multiplication (4, 5, 7), certain compounds were found to be of particu- 
lar interest. Three such compounds have been studied with poliovirus type 2, 
and the results are summarized in Table IV and in Text-fig. 6. 
2-Ethyl-5-methylbenzimidazole was the most selective compound among the 
alkyl derivatives studied with influenza virus (4). Furthermore, this compound 
was nineteen times more active than benzimidazole. As an inhibitor of polio- 
virus, the 2-ethyl-5-methyl derivative was not significantly different from the 
reference compound in selectivity of action, and its relative inhibitory activity 
was 7.2. 
5-(or 6-)Bromo-4,5-(or 5,7-) dichloro-l-~-D-ribofuranosylbenzimidazole was, 
among the compounds examined, the most active and selective inhibitor of 
influenza virus multiplication (5). This compound was 1950 times more active oD 
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than benzimidazole. With poliovirus,  the relative inhibitory activity was 670, 
and it was not significantly more selective than benzimidazole. 
Finally, 5-methyl-2-D-ribobenzimidazole was remarkable in that it increased 
the yield of influenza B virus (7). With poliovirus this compound showed slight 
inhibitory activity on virus yield. 
None  of  these  derivatives  showed  protective  activity  against  poliovirus- 
induced cell damage. 
TABLE IV 
Poliovirus Type 2 Inhibitory Activity and Sdectivity of Certain Benzimidazole Derivatives in 
Monkey Kidney Calls in Vitro 
Benzimldazole derivative 
Benzlmidazole 
2-Ethyl-5-methyl 
5-(or 6-)Bromo-4, 6-(or 5, 7-)dichloro-l-B- 
D-ribofuranosyl  i 
5-Methyl-2-D-ribo  ] 
75 per cent 
virus 
inhibitory 
concentratior 
DM 
2800 
390 
~4,2 
~5200 
Relative 
inhibitory 
activity 
I 
7,2 
~670 
~0, 54 
3+ toxlq 
concen- 
tration 
~M 
5200 
~680 
~8.4 
>5200 
Selec- 
Relative  tivity 
toxicity i  ratio 
I  1,9 
~7.£  ~1.7 
~620  ~2.0 
<l.C  >1.0 
Relative 
selectivit~ 
t 
~0.89 
>0.53 
H.  Characteristics  of  Poliovirus  Type  2  Inhibition  by  2-(ce-Hydroxybenzyl)- 
benzimidazole  (HBB) 
Photomicrographic  Demonstration  of Inhibition by ItBB of Virus-Induced Cell 
Damage.--Inhibition  of poliovirus cytopathic effects by HBB is illustrated  in 
photomicrographs  of monkey kidney  cells  shown  in  Figs.  1  to  11.  In  these 
experiments  the amount of poliovirus inoculated was 500 TCID60 per culture, 
and  the  number  of cells  per  culture  was  approximately  2.5  X  10 ~.  The  con- 
centration of HBB was 493/~M. 
Cultures shown in Figs.  1 to 4 were photographed 48 hours after the beginning of 
the experiment. Fig. 1 demonstrates the appearance of normal cells in an uninfected 
untreated culture. Lack of effect of HBB on the microscopic appearance of uninfected 
monkey kidney cells is illustrated  in Fig. 2. The cytopathic effects  of poliovirus type 
2 can be seen in Fig. 3. Most of the cells have fallen off the glass and the few remaining 
cells show marked  contraction and  rounding up of the cytoplasm. Fig. 4  shows an 
infected culture incubated in the presence of HBB. It is evident that the compound 
has prevented  the occurrence of viral cytopathic changes at this time. 
The findings at 96 hours are illustrated  in Figs. 5 to 8. The appearance of cells in 
uninfected treated cultures  (Fig. 6)  was similar to that in uninfected untreated  cul- 
tures (Fig. 5). In the infected untreated cultures (Fig. 7) only a few severely damaged 
cells remained  on glass.  In treated  infected cultures  (Fig.  8)  a  moderate number of 
cells  were  undergoing degenerative  changes due  to poliovirus,  although  many  still 
appeared normal. TAMM  ET  AL.  647 
4+ 
2+ 
1+ 
o'3 
0  0 
0 
"0 
0 
'0 
Q)  3*  O 
c 
I 
c 
o  i+ 
cu 
S 
O 
o  0 
,,~+ 
3~" 
2+ 
2-Ethyl- 5-methylbenz/midazole 
•  78"r/~]"1 =2.0  x75  pe~cen1~'VIC 
o  525-- 
•  350 
•  v  -  •  - 
~  I  I  I  I  I 
5-(ot~ 6-1Br'omo-4,6- (oz, 5,7-) dichlof,o-l- (3-D- 
.t,ibofuranosylbenzirnidazole 
8.55/~M= 2.0  ×"/5 pe~ cent, VIC 
o  5.55 
3.'/0 
5 -t.'Iethyl  - 2-D-  x~i  bobenzirnidazole 
5,250/.zM  = 1.0  x 75 ?eecent VIC 
3~  500-- 
•  2, 3,~ 
0  l  i  !  _ 
1  2  3  ~  5  6  7 
Day5 
TExT-FxG. 6.  Compound-induced damage-tlme curves with certain benzimidazole derlva- 
fives in monkey kidney cells. 548  VIRUS  INHIBITORY  ACTIVITY  OF  BENZIMIDAZOLES 
In view of the appearance at 96 hours of viral lesions in treated cultures, the pos- 
sibility was investigated that the compound had been inactivated during the interval 
between 48 and 96 hours. The results are illustrated in Figs. 9  to  11. The  cultures 
shown in  Figs. 9 to  11 were photographed  at 96 hours. Fig. 9 illustrates the extent 
of virus-induced damage in infected cultures which were  treated with HBB  for 96 
hours without a  change in medium. Fig. 10 shows an infected treated culture whose 
medium was replaced with a fresh solution of compound at 48 hours. As can be seen, 
the extent of virus-induced cell damage in this culture is similar to that in the culture 
(Fig. 9) in which the HBB-containing medium was not changed. Clearly, the develop- 
ment of virus-induced cell damage in treated cultures on prolonged incubation was 
not  due  to  inactivation  of  HBB. 
Fig.  11  shows a  culture whose medium, containing compound, was replaced at 48 
hours with  control medium without  compound.  This culture showed more marked 
viral changes  than  the  cultures which were  treated with  compound  for  the  entire 
96-hour period. Thus, the suppressive effect of HBB on viral activity was reversible, 
as removal of compound was followed by increased viral activity. 
Effects of Size of Virus Inoculum and Concentration of Compound on Inhibition 
of Virus-Induced  Cell Damage by ttBB.- 
Monkey kidney cell cultures were  inoculated with  varying amounts  of poliovirus  and 
incubated in the presence or absence  of HBB which was used at two concentrations.  The 
amount of virus inoculated per culture was 50, 500, or 5000 TCIDs0, and the concentration 
of HBB was 493 or 740/~. The cultures were examined daily for 6 days and virus-induced 
cell damage was recorded as per cent cells affected. 
The mean results of two  such experiments are shown  in Text-fig.  7.  At 24 
hours the extent of virus-induced damage in untreated cultures was approxi- 
mately proportional to the amount  of virus inoculated; at 2  days viral cyto- 
pathic changes in untreated cultures were near maximal regardless of the  size 
of the inoculum. The curves depicting the course of events in treated  cultures 
show  that  the cell protective effect varied directly with the concentration  of 
compound,  and  inversely with  the  size  of virus  inoculum.  With  the  lowest 
virus inoculum  (50 TCIDs0)  and the higher concentration of HBB  (740  ~), 
virus-induced cell damage was delayed 4 days; with the highest virus inoculum 
(5000  TCIDs0)  and  the lower concentration  of compound  (493  #M)  the  viral 
cytopathic changes were delayed about 2 days. 
Relationship between Time of Addition of H B B and Inhibition  of Virus-Induced 
Cell Damage.--In experiments on the relationship between time of addition of 
HBB  and  inhibition of poliovirus cytopathic effects in monkey kidney cells, 
the amount  of virus used in the inoculum was  2  X  l0  s or 5  X  l0  s TCIDs0, 
and HBB was added 30 minutes before virus inoculation, along with the virus, 
or at varying intervals after virus inoculation. 
The experiments with the lower inoculum were carried out in the usual manner.  In experi- 
ments with the higher inoculum cultures were washed twice with warm Eagle's medium with TAM~  ET  AL.  649 
or without HBB 30 minutes after virus inoculation to remove unadsorbed virus. The washing 
was carried out at 24°C., and the time required was subtracted from the total time between 
virus inoculation and addition of compound. In both kinds of experiments control groups 
of infected cultures received an equal volume of medium, but no compound. The cultures 
were examined at intervals and virus-induced cell damage was recorded as per cent cells 
affected. 
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tion by 2-(~-hydroxybenzyl)-benzimid~le (HBB) of poliovirus type 2-induced cell damage 
in monkey kidney cells. 
Text-fig. 8 depicts the mean results  of two experiments in which 2  X  l0  s 
TCID60 of virus was inoculated per culture. It should be mentioned that under 
the  conditions  used,  earliest  evidence of viral  cytopathic effects  in  the  un- 
treated controls was observed 6 to 8 hours after inoculation. As can be seen in 
Text-fig. 8, HBB was capable of causing marked inhibition of viral cytopathic 
effects when given as late as 3  to 5 hours after virus inoculation; i.e.,  during 
the exponential phase of poliovirus multiplication (22). This suggests that HBB 
may inhibit a  late step in the reproductive sequence of poliovirus. 650  VIRUS  INHIBITORY  ACTIVITY OF BENZIMIDAZOLES 
In two experiments in which the inoculum was 5  X  102 TCID~0 per culture, 
the  extent  of  virus-induced  damage  in  untreated  controls  at  24  hours  was 
equivalent to approximately 3  per cent involvement of the monolayer. At 48 
hours,  approximately 90 per cent of cells in  untreated  infected cultures  were 
markedly  altered,  whereas  in  cultures  which  had  received  HBB  24  hours 
previously,  only 20  per  cent  of  cells  showed  viral  cytopathic  effects at  this 
time. These results are in line with those described above. 
Lack o/Inactivating Effect  of HBB on  Virus Infectivity.--Stability  of polio- 
virus in  the presence of HBB  was studied  at a  final dilution  of 1:100  of the 
seed virus preparation  in protein-free Eagle's medium. 
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TExT-FIG.  8. Relationship between time of addition of  2-(a-hydroxybenzyl)-benzimidazole 
(HBB) and inhibitory effect on poliovirus type 2-induced cell damage in monkey kidney cells. 
Extent of  virus-induced cell  damage was  determined at  constant time,  i.e.  24 hours after 
inoculation. 
No  inactivation  of  poliovirus  by  the  compound  occurred  when  the  virus 
was incubated with  1,100  #M HBB for 40 hours or with 4,400  ~  HBB for 3 
hours. 
Lack of Inhibitory Effect  of HBB on Multiplication and Cytopathogenicity  o/ 
Influenza B  Virus in Monkey Kidney Cells.--It was shown above that HBB had 
no inhibitory effect on production of influenza  B  virus in  the chorioallantoic 
membrane in vitro. Experiments were carried out  to  determine the  effects of 
HBB on the yield of influenza B virus in monkey kidney cells and on cytopathic 
changes  caused  by  this  virus.  The  experimental procedures  were  similar  to 
those used with poliovirus. 
HBB at a  concentration of 740 #~ had no effect on the yield of influenza B 
virus in  monkey kidney cells,  as  determined  by hemagglutination  titrations. 
In a separate experiment with  493  t~  HBB, the yield of virus was measured 
by both hemaggluti~ation  and  infectivity titrations.  The compound  had no TAMMET  AL.  651 
effect on virus yield as measured by either procedure. The results summarized 
in Text-fig. 9  show that  HBB  did not protect ceils  against influenza virus- 
induced damage. 
Experiments  were  also  carried  out  to  determine  whether  HBB  had  any 
effects on the yield of influenza A virus in the chorioallantoic membrane in 
vitro. No inhibition or enhancement of yield was observed in experiments in 
which 3.2 ×  105 EID~0 of the PR8 strain of influenza A virus was inoculated 
per culture, the concentration of HBB was 1110 or 3770 g~, the cultures were 
incubated for 41 hours, and the virus was measured by the hemagglutination 
procedure. 
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TEXT-FIO. 9.  Lack of inhibitory effect of 2-(ol-hydroxybenzyl)-benzimidazole  (HBB)  on 
influenza B  virus-induced cell damage in monkey kidney cells. 
DISCUSSION 
The  demonstration  that  2-(~-hydroxybenzyl)-benzimidazole  (HBB)  and 
certain related derivatives possess selective inhibitory activity on poliovirus 
type 2 multiplication adds another group of compounds to the growing list of 
benzimidazole  derivatives  with  remarkable  effects  on  virus  multiplication. 
It should be emphasized that each group is characterized by a different set of 
structure-activity relationships. 
HBB is remarkable, because it is among the first synthetic chemical com- 
pounds to show significant biological selectivity in its virus inhibitory action. 
At concentrations which cause marked inhibition of poliovirus type 2 multipli- 
cation, this compound has no effect on the multiplication of influenza B virus, 
and it shows no or only slight effects on the microscopic structure of monkey 
kidney cells. Finally, HBB, and its 5-chloro derivative, are the only synthetic 
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genicity. The 5-chloro derivative is 1.6 times more active, but also more toxic 
than HBB. 
In the communication which follows,  the virus inhibitory spectrum of HBB 
is described, and the remarkable selectivity of HBB is fully brought out (23). 
As  will be  shown,  HBB  has  no  inhibitory effects on  the  several  metabolic 
activities of monkey kidney cells  which have been studied.  Furthermore,  it 
does not inhibit the growth of cells. The usefulness of HBB as an aid in virus 
classification has been established (24). 
As to the mechanism of action of HBB, it should be emphasized that this 
compound has  no direct  inactivating effect on the  infectivity of poliovirus. 
HBB appears to be capable of interfering with a late step in the reproductive 
sequence of poliovirus. There  is evidence that HBB inhibits viral cytopathic 
effects through inhibiting virus multiplication. The inhibitory effect of HBB is 
reversible  in  that  after  removal  of  the  compound,  increased  viral  activity 
develops. 
Studies of the structure-activity relationships with HBB and related com- 
pounds have suggested that the hydroxybenzyl grouping at position 2 in the 
imidazole ring of the benzimidazole molecule is of fundamental importance for 
the selective virus inhibitory action of HBB.  The structural and metabolic 
(23) evidence which is available does not suggest that HBB acts as an antago- 
nist of a metabolite required both by the host cell and the virus; indeed, there 
is strong evidence against such a possibility. The subject of metabolic antago- 
nism and selective virus inhibition is discussed in detail elsewhere (25),  and 
the selective virus inhibitory action of HBB is compared with that of M-8450, 
helenine, and interferon. 
The new, highly active inhibitors of ribonucleic acid (RNA)  biosynthesis, 
described previously (2, 3,  5,  8), are/t-linked ribofuranosides of halogenated 
benzimidazoles,  and  they have  played  a  significant part  in  studies  on  the 
requirements and mechanism of virus multiplication (8, 9,  12-15),  as well as 
in studies on the role of RNA in protein synthesis (16, 17). 
Finally,  certain  structurally  very  different  derivatives  of  benzimidazole 
possess the unique ability of increasing the yield of influenza virus from infected 
tissue without affecting the metabolic activities of the cells  (11,  18).  These 
derivatives  are  2-(aldopolyhydroxyatkyl)-benzimidazoles, of which  the  com- 
pound that has been studied most intensively  is  5-methyl-2-D-ribobenzimi- 
dazole. 
Clearly, certain benzimidazole derivatives have opened new approaches  to 
the problems of the mechanism and requirements of virus multiplication and 
the mechanisms of virus-induced cell damage. It should be mentioned, however, 
that numerous benzimidazole derivatives which have been examined for virus 
inhibitory activity have been found to be inactive or have shown virus inhibi- 
tory activity of variable degree accompanied by low selectivity of action. In the T#~r~  ET  AL.  653 
present studies, much new  evidence was  obtained indicating that  extensive 
substitution in either the benzenoid or imidazole ring frequently gives com- 
pounds of very high inhibitory activity on virus multiplication. However, no 
highly selective inhibitors of influenza virus multiplication were found. 
Some years ago (8) the view was expressed that there appeared to be numer- 
ous as yet untapped possibilities for increasing the virus-inhibitory effectiveness 
of benzimidazole derivatives through further modification of structure.  This 
prediction has been fulfilled; yet, the same prediction may be made again with 
even greater justification than before. 
SUMMARY 
The  virus  inhibitory  activity  and  selectivity  of  certain  benzimidazole, 
benzotriazole, and naphthimidazole derivatives were determined with influenza 
B and polio type 2 viruses. 
Among  the  sixty-five  compounds  examined,  several  were  highly  active 
inhibitors of influenza B virus multiplication in the chorioallantoic membrane 
in vitro.  The following compounds, listed in order of increasing inhibitory ac- 
tivity, were more than 100 times as active as benzimidazole: 5-(4~-toluenesulfo - 
namido)-benzimidazole,  5-hydroxybenzotriazole-4-carboxy-a-naphthylamide, 
4,5,6-trichlorobenzotriazole,  5-(3', 4t-dichlorobenzenesulfonamido)-benzimi  - 
dazole,  5-(3',4'-dichlorobenzenesulfonamido) -  1 -  (3",4" - dichlorobenzene- 
sulfonyl)-benzimidazole,  4-(p-chlorophenylazo)-5-hydroxybenzotriazole,  and 
4,5,6,7-tetrachlorobenzotriazole. However, none showed high selectivity. 
Of the sixty-five compounds studied with influenza virus, twenty-five were 
also examined with poliovirus type 2 in monkey kidney cells in vitro. Included 
in this group were five of the seven most active inhibitors of influenza virus, 
listed above. All five were more than 100 times as active in inhibiting polio- 
virus multiplication as the reference compound. In addition to these, two other 
compounds  were  highly  active:  2-(o~-hydroxybenzyl)-benzimidazole (HBB), 
and  2-(a-hydroxybenzyl)-5-chlorobenzimidazole,  with  relative  inhibitory 
activities of 78 and 130, respectively. These two compounds, and the much less 
active  5,6-dichloro  derivative  of  HBB,  were  the  only ones  which  showed 
no, or only slight, toxic effects on cells  at concentrations sufficient to cause 
considerable inhibition of poliovirus multiplication.  Furthermore,  HBB  and 
the  5-chloro  derivative  were  the  only compounds which  caused  significant 
inhibition of the cytopathic effects of poliovirus. 
HBB,  and its 5-chloro  and 5,6-dichloro  derivatives had no effect on the 
multiplication of influenza B virus in the chorioallantoic membrane. In addi- 
tion, HBB  failed to  inhibit influenza B  virus multiplication and cytopathic 
effects in monkey kidney cells. 
Inhibition of poliovirus-induced cell damage by HBB was characterized by 
the following features: the curves relating reduction in virus yield or cytopathic 654  VIRUS  INItI33ITORY  ACTIVITY  O]?  BENZI~IDAZOLES 
effects to concentration of the compound followed an approximately parallel 
course; somewhat higher concentrations were required to inhibit virus-induced 
cell  damage  than  to  reduce  virus  yield.  HBB  suppressed  viral  cytopathic 
effects for a  period of time which varied directly with the concentration of 
compound, and inversely with the size of virus inoculum. The development of 
virus-induced cell damage in treated cultures on prolonged incubation was not 
due to inactivation of HBB. The inhibitory effect of HBB on virus-induced cell 
damage  was  reversible  by removal  of  the  compound.  HBB  inhibited viral 
cytopathic effects when given during the exponential increase phase in virus 
multiplication. Inhibition of virus-induced cell damage by HBB was demon- 
strated by photomicrographs. HBB did not inactivate the infectivity of polio- 
virus type 2. 
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EXPLANATION  OF PLATES 
PLATE 70 
Black and white photomicrographs of monkey kidney cells demonstrating inhibi- 
tion of poliovirus-induced cell damage by 2-(a-hydroxybenzyl)-benzimidazole  (HBB). 
The  amount  of poliovirus type 2  inoculated was  500  TCIDs0  per culture and  the 
concentration of HBB  was 493  #M.  Cultures  were  incubated  for 48  hours.  X  160. 
FIG.  1.  Uninfected,  untreated  culture. 
FIG.  2.  Uninfected,  treated  culture. 
FIG.  3.  Infected,  untreated  culture. 
FIG.  4.  Infected,  treated  culture. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 113  PLATE  70 
(Tamm  et  al.: Virus inhibitory activity of benzimidazoles) PLATE 71 
Black and white photomicrographs of monkey kidney cells demonstrating inhibi- 
tion of poliovirus-induced cell damage by 2-(c~-hydroxybenzyl)-benzimidazole  (HBB)o 
The  amount of  poliovirus type  2  inoculated was  500 TCIDs0 per  culture and  the 
concentration of  HBB  was  493 #M.  Cultures were  incubated for  96  hours.  ×  160. 
FIG.  5.  Uninfected, untreated culture. 
FIG.  6.  Uninfected, treated  culture. 
FIG.  7.  Infected,  untreated  culture. 
Fro.  8.  Infected,  treated  culture. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 113  PLATE  71 
(Tamm  et  al.:  Virus inhibitory activity of benzimidazoles) PLATE 72 
Black and white photomicrographs of monkey kidney cells demonstrating inhibition 
of poliovirus-induced cell damage by 2-(a-hydroxybenzyl)-benzimidazole  (HBB). The 
amount of poliovirus type 2 inoculated was 500 TCIDs0 per culture and the concen- 
tration of HBB was 493 #~.  Cultures were incubated for 96 hours.  X  160. 
FIG. 9.  Infected culture, treated  with  HBB  for  96  hours;  me(lium  not  changed. 
Fro.  10.  Infected culture, treated  with  HBB  for  96  hours; at 48  hours  medium 
containing HBB  replaced  with  fresh  HBB-containing medium. 
FIG. 11.  Infected culture, treated  with  HBB  for  48  hours; at 48  hours medium 
replaced  with  fresh  medium  without  HBB. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  113  PLATE  72 
(Tamm  et  al. : Virus inhibitory activity of benzimidazoles) 